Lupin to train over 1,000 graduates for pharma industry
Mumbai-based Lupin expects to train more than 1,000 under graduates into pharma professionals by the year 2020 under its ‘Learn and Earn Initiative’.
Under this initiative, candidates who have passed Standard 12 in the science stream with a minimum of 50 per cent marks but are facing financial constraints, are taken for three-year-long course during which they are paid stipend and provided all facilities.
According to Mr. Yashwant Mahadik, President, Global Human Resource, Lupin, the programme was conceptualised in 2010 due an acute shortage of skilled manpower. “Historically, Lupin was recruiting 1,000 plus fresh graduates every year with no relevant job skill, and sensed that there was a need of job-ready graduates with appropriate technical and life skills,” he said.
Mr. C. Srinivasalu, Senior Vice President (HR), Lupin, informed that since 2011 the company has helped create a total of 560 graduates with 181 students passing out in 2018. “We expect to graduate more than 1,000 students by 2020 adding to the manpower resource of the pharmaceutical sector,” he said.
The company has initiated the ‘Learn and Earn Initiative’ at its facilities in Goa, Tarapur (Maharashtra), Indore (MP), Aurangabad (Maharashtra) and Sikkim, he added.
During the course period, the candidate undergoes five days on-the-job training with one day of classroom session. Further, the students have to compulsorily work with Lupin for two years, after completing their course before they have their options open to join any other pharmaceutical firm.
Lupin has estimated that by the year 2020 it would be spending almost Rs. 20-crore on this programme. This programme will bridge the manpower requirement of pharmaceutical sector in a big way, said Mr. Srinivasalu.
Looking for chemical products? Let suppliers reach out to you!
2026-07-11
-
Life Sciences Industry Overview
The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.Published in: June.2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Alipay, Baidu, and iFlytek Win Big—As the Government Spends $1.1 Billion on AI Healthcare, Is This a Lifeline or a Feeding Frenzy for Tech Giants?
-
Sun Pharma’s Secret Sauce: Solve the Specific, Win the Market
-
The Oral GLP-1 Cage Match: Orforglipron vs Rybelsus
-
Sun Pharma’s Winning Formula: Precision Over Expansion
-
Merck to Lay Off 150 Workers at US Gardasil Plant Amid Sales Weakness
-
The Pill That Could Swallow the Needle: Novo Nordisk Launches Oral Wegovy in U.S. Weight-Loss Revolution
-
The $6 Billion Gold Rush: Generic Semaglutide Set to Reshape Global Pharma After Patent Cliff
-
AstraZeneca India Eyes ₹3,400 Crore Bengaluru Sale
-
Iran Conflict Leaves a Long Shadow on Drug Supply
-
Sun Pharma’s Organon Bid Would Redraw Indian Pharma M&A
Recommend Reading
-
Lilly Eyes Fast-Track Approval for Oral Weight-Loss Drug in U.S.
-
Merck and Eisai Halt Late-Stage Trial for Liver Cancer Therapy
-
U.S. Health Chief Says No Evidence Linking Tylenol to Autism
-
Pfizer Sues Metsera and Novo Nordisk Over Rival Obesity Drug Strategy
-
India Strengthens Drug Approval Oversight with Expanded CDSCO Powers
-
Nepal’s Rice Planting Rate Hits 91 Percent After Heavy Rains Madesh and Koshi Regions Rebound from Drought
-
The Capital Undercurrent in the Desert: China’s Banks, Saudi Gas, and the “Absent” Chinese Funds
-
Dibutyl Phthalate: Plastic Applications, Properties & Safety
-
When Soybeans Lose Weight, Fertilizers Take the Stage: The Industrial Chain Reaction Behind U.S. Farm Subsidies
-
DIC Opens Sustainable Food Contact Coatings Production Facility in Indonesia